Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
about
Effects of vascular endothelial growth factors and their receptors on megakaryocytes and platelets and related diseases.The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use
P2860
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@en
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@nl
type
label
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@en
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@nl
prefLabel
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@en
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@nl
P2860
P356
P1476
Advances in understanding the pathogenesis of familial myeloproliferative neoplasms.
@en
P2093
Mario Cazzola
P2860
P304
P356
10.1111/BJH.14713
P407
P50
P577
2017-04-25T00:00:00Z